0000947871-24-000616.txt : 20240715 0000947871-24-000616.hdr.sgml : 20240715 20240715194847 ACCESSION NUMBER: 0000947871-24-000616 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240715 DATE AS OF CHANGE: 20240715 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001831363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39926 FILM NUMBER: 241118387 BUSINESS ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-525-5535 EXT.101 MAIL ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: ORBIMED ADVISORS LLC CENTRAL INDEX KEY: 0001055951 ORGANIZATION NAME: IRS NUMBER: 133976876 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: 601 LEXINGTON AVENUE STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 739-6400 MAIL ADDRESS: STREET 1: 601 LEXINGTON AVENUE STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 144 1 primary_doc.xml 144 0001055951 XXXXXXXX LIVE 0001831363 Terns Pharmaceuticals, Inc. 001-39926 1065 East Hillsdale Blvd., Suite 100 Foster City CA 94404 650-525-5535 OrbiMed Genesis Master Fund, LP Director Shareholder Common Stock TD Cowen

599 Lexington Avenue New York NY 10022

152400 1418844.00 64677145 07/15/2024 Nasdaq Common Stock 08/12/2022 Private Placement Issuer N 152400 08/12/2022 Cash Y OrbiMed Genesis GP LLC is the general partner of OrbiMed Genesis Master Fund, LP. OrbiMed Advisors LLC is the managing member of OrbiMed Genesis GP LLC. 07/15/2024 /s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors LLC, managing member of the general partner of OrbiMed Genesis Master Fund, LP